ANGPT2 and endothelial dysfunction: Notably, in an abstract presented at the American Society of Hematology (ASH) 2024 meeting, a Spanish study of 110 patients with lymphoma and MM receiving CAR T-cell therapy showed a positive correlation between both EASIX and mEASIX and biomarkers of endothelial dysfunction, Ang-2 and suppression of tumorigenicity 2 (ST2).